FDCDDQ
KRYS icon

Federation des caisses Desjardins du Quebec’s Krystal Biotech KRYS Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.9K Hold
50
– – ﹤0.01% 2234
2025
Q4 		$12.3K Hold
50
– – ﹤0.01% 2191
2025
Q3 		$8.83K Hold
50
– – ﹤0.01% 2305
2025
Q2 		$6.87K Hold
50
– – ﹤0.01% 2175
2025
Q1 		$9.02K Hold
50
– – ﹤0.01% 1998
2024
Q4 		$7.83K Hold
50
– – ﹤0.01% 1955
2024
Q3 		$9.1K Hold
50
– – ﹤0.01% 1911
2024
Q2 		$9.18K Hold
50
– – ﹤0.01% 1832
2024
Q1 		$8.9K Hold
50
– – ﹤0.01% 1841
2023
Q4 		$6.2K Hold
50
– – ﹤0.01% 1859
2023
Q3 		$5.8K Hold
50
– – ﹤0.01% 1880
2023
Q2 		$5.87K Hold
50
– – ﹤0.01% 1875
2023
Q1 		$4K Buy
+50
New +$3.93K ﹤0.01% 1961

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's KRYS Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Krystal Biotech (KRYS) position steady in Q1 2026 at 50 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2234.

Federation des caisses Desjardins du Quebec first reported a position in KRYS in Q1 2023 and has held it in 13 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 50 shares of Krystal Biotech worth $12.9K as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Krystal Biotech share count unchanged in Q1 2026.
  • Krystal Biotech made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2234 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Krystal Biotech in Q1 2023 and has held it in 13 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.